Browsing Tag
Reserve Bank of Australia
15 posts
Australia rate risk returns after RBA board debated fourth 2026 interest-rate increase
Reserve Bank of Australia minutes show several board members believed inflation risks could require additional tightening even as the board unanimously held rates.
National Australia Bank (ASX: NAB) shares fall 4.6% as A$1.8bn cash earnings collide with mortgage slowdown
NAB cash earnings rose to A$1.83bn, but a 15% fall in mortgage applications and higher watch loans sent ASX: NAB down 4.6% as credit risks emerged.
Commonwealth Bank of Australia (CBA) posts A$10.98bn FY26 profit as system-plus growth meets cost scrutiny
Commonwealth Bank of Australia's A$10.98 billion FY26 cash profit and A$5.05 dividend clash with a 2% share drop, raising the FY27 cost and margin question.
The big banks bleed: Why the S&P/ASX 200 Financials Index (XFJ) is staring at a fresh three-month low
Banks are repricing faster than retail investors expected. The RBA went hawkish, Westpac's margins slipped, NAB's profit dropped. The 16 June meeting decides the next leg.
Xero (ASX: XRO) climbs into FY2026 result as Melio integration becomes the central thesis test
Xero spent US$2.5bn on Melio. Shares are down 57% from the highs. The May 14 result is when bulls and bears find out who was right.
REA Group (ASX: REA) shares jump as Q3 FY2026 result lifts cost guidance and confirms residential recovery
REA Group fell 9.6% on H1 results in February. Today's Q3 print rewrites that thesis. Listing volumes are back, yield is at 14%, costs are being held.
ASX 200 climbs to two-week high as miners reignite commodity supercycle trade, BHP, Rio Tinto and Sandfire lead broad materials rally
Base metals are flat. Iron ore hasn't moved. So why are BHP, Rio Tinto and Sandfire ripping the ASX 200 to a two-week high? Sentiment is rotating fast.
ASX 200 ends 8-day losing streak as 73% of stocks rebound, only Energy lags
Australia's longest losing streak since 2018 just broke. The bounce is real, but breadth and Energy reversal hint at consolidation, not recovery.
Pepper Money (ASX: PPM) rejects Challenger’s revised A$2.25 bid, ending takeover talks
Pepper Money rejects Challenger's A$2.25 takeover bid as not executable. What it means for PPM shareholders, CGF strategy, and Australian non-bank lending M&A.
ASX healthcare sector falls harder than the broader market as rate shock and Middle East war pressure high-multiple stocks
ASX healthcare stocks fell 2.47% on 19 March, lagging every other defensive sector. Here's what's driving CSL, Pro Medicus and Cochlear lower. Read more.